PAPA (Papa Medical) NonCurrent Deferred Liabilities: $0.00 Mil (As of Mar. 2025)


What is Papa Medical NonCurrent Deferred Liabilities?

Papa Medical PAPA NonCurrent Deferred Liabilities is $0.00 Mil as of Mar. 2025.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Papa Medical's non-current deferred liabilities for the quarter that ended in Mar. 2025 was $0.00 Mil.

Papa Medical NonCurrent Deferred Liabilities Related Terms

Papa Medical NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Papa Medical's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical NonCurrent Deferred Liabilities Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
0.00 0.00 0.00

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a NonCurrent Deferred Liabilities of $0.00 Mil mean?
Papa Medical (PAPA) has a NonCurrent Deferred Liabilities of $0.00 Mil as of Mar. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Papa Medical and its competitors.
Is Papa Medical's NonCurrent Deferred Liabilities too high?
Papa Medical's current NonCurrent Deferred Liabilities is $0.00 Mil.
How does Papa Medical's NonCurrent Deferred Liabilities compare to ?
Papa Medical's NonCurrent Deferred Liabilities of $0.00 Mil can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Tobacco Products company?
A good NonCurrent Deferred Liabilities depends on the Tobacco Products industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Papa Medical and its competitors. Papa Medical's current NonCurrent Deferred Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current NonCurrent Deferred Liabilities of $0.00 Mil. The current NonCurrent Deferred Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Papa Medical (PAPA), the current NonCurrent Deferred Liabilities is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.